ROCHESTER, Minn. (WCCO) — A study from the Mayo Clinic Cancer Center has found that cancer patients who are undergoing chemotherapy and certain other treatments may have an “inadequate” immune response to COVID-19 vaccination.
The findings, published in Mayo Clinic Proceedings, says this inhibited response to vaccination is also showing up for those with targeted therapies, like CDK 4/6 inhibitors and therapies targeted at B cells.READ MORE: Good Question: How Do Trees Know When To Bloom?
Cancer treatment patients are still urged to get vaccinated – and boosted.
“It is important for patients with cancer who are receiving chemotherapy to receive a COVID-19 vaccine,” said Saranya Chumsri, M.D., a Mayo Clinic hematologist and oncologist.READ MORE: Minnesota Companies Mining Gold From Nostalgia For Decades Gone By
Chumsri, who authored the study, is recommending these patients have their antibody levels tested after vaccination.
“Dr. Chumsri anticipates having additional data later this year regarding broader immune responses to COVID-19 vaccinations, including cellular and antibody responses in patients receiving chemotherapy and targeted therapies with booster vaccinations,” the release said.MORE NEWS: After Her Kids Were Hacked, Cybersecurity Engineer Writes Children's Book
Read more on the study here.